Lutzomyia
Lutzomyia is a genus of sandflies in the subfamily Phlebotominae, which are known vectors of various diseases, including Leishmaniasis and Bartonellosis. The genus is named after the German entomologist Eduard Lutz.
Taxonomy[edit]
The genus Lutzomyia belongs to the family Psychodidae, subfamily Phlebotominae. It was first described by the Brazilian entomologist Adolpho Lutz in 1905. The genus includes over 400 species, many of which are vectors of human diseases.
Distribution[edit]
Lutzomyia species are found in the tropical and subtropical regions of the Americas, from the southern United States to northern Argentina. They are particularly prevalent in the Amazon rainforest.
Disease transmission[edit]
Lutzomyia sandflies are vectors for several diseases, most notably Leishmaniasis and Bartonellosis. They transmit these diseases to humans and other mammals through their bite.
Leishmaniasis[edit]
Leishmaniasis is a disease caused by protozoan parasites of the genus Leishmania, which are transmitted to humans by the bite of infected Lutzomyia sandflies. There are three main forms of the disease: cutaneous, mucocutaneous, and visceral, each of which presents different symptoms and requires different treatments.
Bartonellosis[edit]
Bartonellosis, also known as Carrion's disease, is caused by the bacterium Bartonella bacilliformis, which is transmitted by Lutzomyia sandflies. The disease is endemic in the Andean regions of Peru, Ecuador, and Colombia.
Control[edit]
Control of Lutzomyia sandflies and the diseases they transmit is a major public health challenge. Strategies include the use of insecticides, bed nets, and repellents, as well as public education about the risks and prevention of sandfly bites.
See also[edit]
Lutzomyia[edit]
-
Lutzomyia longipalpis sandfly
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
